PPD has backed clinical trial preparation software developer Medable as an existing investor having also partnered the business to launch a telemedicine-based clinical trial product last year.
Author: Callum Cyrus
Near Protocol collates fresh funding
The blockchain software deployment service has raised $21.6m to follow a series A round last year that included contributions from Coinbase Ventures, Ideo Colab Ventures and Ripple’s Xpring.
Boohee sweeps series C capital
The food and nutrition business picked up backers including Fosun International and existing investor Qualcomm Ventures after earlier rounds in 2011 and 2014.
Zeitgold treasures series B funding
Deutsche Bank and Axa Innovation Campus featured in a $29.2m round that brought enterprise book-keeping app developer Zeitgold’s funding haul to approximately $57m.
Dailyhunt tracks down more series G funding
ByteDance-backed news and entertainment aggregator Dailyhunt increased its total funding to around $183m after a series G extension from James Murdoch-aligned Lupa India.
ZAF Energy stores $22m
ZAF Energy Systems has raised $45.6m to date after a series A round that featured the corporate venture capital arm of Holt Cat.
Flagstone stakes $14.9m
The cash account marketplace lured the return of Moneysupermarket in a series B round that brings its funding total to $29.2m.
Lenovo lays on series B funding for HGZ Medical
The computer manufacturer’s corporate venturing unit backed a $14.2m round for medical robot developer HGZ Medical that comes after the latter’s series A round in March 2019.
Syngenta seeds accelerator
Fresh from rejuvenating its corporate venturing team, Syngenta has launched a new accelerator in a bid to uncover novel food protein products.
InsideBoard inserts series B funding
Axa Venture Partners and Orange Digital Ventures backed a $27.2m round that will fund product development and international growth for the employee engagement software provider.
Amply Power ramps up with new funding
Siemens has invested in Amply as part of a $13.2m round that came just three months after the EV charging service closed its seed funding.
LifeSprout bolts on series A funding
Medytox-backed restorative materials technology developer Lifesprout secured $28.5m in a round led by Redmile Group as it looks to move into regenerative medicine.
Compass points to $80m series B
Otsuka Pharmaceuticals’s McQuade Center for Strategic Research and Development backed the psilocybin-based mental health drug developer through the round.
Starbucks and Sequoia brew Chinese investment pact
The coffee chain has selected Sequoia Capital China as its partner for a strategic investment campaign in one of its two largest growth markets.